Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 (Ape1/Ref-1) Modulates Antigen Presenting Cell-mediated T Helper Cell Type 1 Responses

被引:10
|
作者
Akhter, Nasrin [1 ]
Takeda, Yuji [1 ]
Nara, Hidetoshi [1 ]
Araki, Akemi [1 ]
Ishii, Naoto [2 ]
Asao, Naoki [3 ]
Asao, Hironobu [1 ]
机构
[1] Yamagata Univ, Dept Immunol, Fac Med, 2-2-2 Iida Nishi, Yamagata 9909585, Japan
[2] Tohoku Univ, Grad Sch Med, Dept Microbiol & Immunol, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808075, Japan
[3] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan
关键词
cytokine; dendritic cell; differentiation; redox regulation; T helper cells; Ape1; Ref-1; IL-12; antigen presenting cell; DNA-REPAIR; INTERLEUKIN-6; RECEPTOR; PROTEIN APE1/REF-1; IL-12; PROLIFERATION; MACROPHAGES; EXPRESSION; DOMAIN; ALPHA; APE1;
D O I
10.1074/jbc.M116.742353
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Apurinic/apyrimidinic endonuclease 1/redox factor-1 (Ape1/Ref-1) is a multifunctional protein possessing DNA repair, redox control, and transcriptional regulatory activities. Although Ape1/Ref-1 plays multiple roles in the immune system, its functions in helper T (Th) cell activation and differentiation are largely unknown. In this study, the function of Ape1/Ref-1 in Th cell activation was analyzed using an Ape1/Ref-1 redox-specific inhibitor, E3330. When splenocytes from OT-II mice, which are ovalbumin (OVA)-specific T-cell receptor transgenic mice, were activated with OVA in the presence of E3330, the induction of IFN--producing OT-II T cells was significantly increased. In contrast, E3330 did not enhance IFN- production from plate-bound anti-CD3 antibody-stimulated CD4(+) T cells in the absence of antigen presenting cells (APCs). Furthermore, E3330-pretreated and OVA-pulsed APCs also enhanced the IFN- production from OT-II T cells. These results suggested that E3330 enhances Th1 responses by modifying APC function. E3330 did not alter the surface expression of MHC-II or the co-stimulatory molecules CD80 and CD86 on APCs. On the other hand, E3330 up-regulated the IL-12 p35 and p40 gene expression, and IL-12 surface retention, but decreased the IL-12 secretion from Toll-like receptor (TLR) ligand-stimulated APCs. These results were confirmed with Ape1/Ref-1 knockdown experiments. Taken together, our findings indicated that the suppression of Ape1/Ref-1 redox function leads to an increased cell surface retention of IL-12 and enhances Th1 responses. This is the first study to demonstrate that Ape1/Ref-1 modulates the IL-12 production and secretion from APCs and controls Th1 immune responses.
引用
收藏
页码:23672 / 23680
页数:9
相关论文
共 50 条
  • [1] Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1)
    Laev, Sergey S.
    Salakhutdinov, Nariman F.
    Lavrik, Olga I.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (09) : 2531 - 2544
  • [2] Apurinic/Apyrimidinic Endonuclease/Redox Factor-1 (APE1/Ref-1) Redox Function Negatively Regulates NRF2
    Fishel, Melissa L.
    Wu, Xue
    Devlin, Cecilia M.
    Logsdon, Derek P.
    Jiang, Yanlin
    Luo, Meihua
    He, Ying
    Yu, Zhangsheng
    Tong, Yan
    Lipking, Kelsey P.
    Maitra, Anirban
    Rajeshkumar, N. V.
    Scandura, Glenda
    Kelley, Mark R.
    Ivan, Mircea
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (05) : 3057 - 3068
  • [3] Changes in the Plasma Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1(APE1/Ref-1) Level during Cancer Surgery: An Observational Study
    Jo, Yumin
    Kim, Yeojung
    Park, Eunhye
    Lee, Yuran
    Kim, Jiyeon
    Kang, Minwoong
    Lim, Jaesung
    Song, Insang
    Lim, Chaeseong
    Jeon, Byeonghwa
    MEDICINA-LITHUANIA, 2021, 57 (11):
  • [4] Design and Synthesis of Novel Quinone Inhibitors Targeted to the Redox Function of Apurinic/Apyrimidinic Endonuclease 1/Redox Enhancing Factor-1 (Ape1/Ref-1)
    Nyland, Rodney L., II
    Luo, Meihua
    Kelley, Mark R.
    Borch, Richard F.
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (03) : 1200 - 1210
  • [5] Apurinic/apyrimidinic endonuclease1/redox factor-1 (Ape1/Ref-1) is essential for IL-21-induced signal transduction through ERK1/2 pathway
    Juliana, Farha M.
    Nara, Hidetoshi
    Onoda, Tadashi
    Rahman, Mizanur
    Araki, Akemi
    Jin, Lianjin
    Fujii, Hodaka
    Tanaka, Nobuyuki
    Hoshino, Tomoaki
    Asao, Hironobu
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 420 (03) : 628 - 634
  • [6] Nuclear depletion of apurinic/apyrimidinic endonuclease 1 (Ape1/Ref-1) is an indicator of energy disruption in neurons
    Singh, Shilpee
    Englander, Ella W.
    FREE RADICAL BIOLOGY AND MEDICINE, 2012, 53 (09) : 1782 - 1790
  • [7] Apurinic/apyrimidinic endonuclease 1 (APE1/Ref-1) overexpression is an independent prognostic marker in prostate cancer without TMPRSS2:ERG fusion
    Juhnke, Manuela
    Heumann, Asmus
    Chirico, Viktoria
    Hoeflmayer, Doris
    Menz, Anne
    Hinsch, Andrea
    Hube-Magg, Claudia
    Kluth, Martina
    Lang, Dagmar S.
    Moeller-Koop, Christina
    Sauter, Guido
    Simon, Ronald
    Beyer, Burkhard
    Pompe, Raisa
    Thederan, Imke
    Schlomm, Thorsten
    Luebke, Andreas M.
    MOLECULAR CARCINOGENESIS, 2017, 56 (09) : 2135 - 2145
  • [8] Levels of the DNA repair enzyme human apurinic/apyrimidinic endonuclease (APE1, APEX, Ref-1) are associated with the intrinsic radiosensitivity of cervical cancers
    Herring, CJ
    West, CML
    Wilks, DP
    Davidson, SE
    Hunter, RD
    Berry, P
    Forster, G
    MacKinnon, J
    Rafferty, JA
    Elder, RH
    Hendry, JH
    Margison, GP
    BRITISH JOURNAL OF CANCER, 1998, 78 (09) : 1128 - 1133
  • [9] APE1/Ref-1 redox function contributes to inflammatory pain sensitization
    Zaky, Amira
    Bouali-Benazzouz, Rabia
    Favereaux, Alexandre
    Tell, Gianluca
    Landry, Marc
    EXPERIMENTAL NEUROLOGY, 2018, 307 : 1 - 11
  • [10] Impact of APE1/Ref-1 Redox Inhibition on Pancreatic Tumor Growth
    Fishel, Melissa L.
    Jiang, Yanlin
    Rajeshkumar, N. V.
    Scandura, Glenda
    Sinn, Anthony L.
    He, Ying
    Shen, Changyu
    Jones, David R.
    Pollok, Karen E.
    Ivan, Mircea
    Maitra, Anirban
    Kelley, Mark R.
    MOLECULAR CANCER THERAPEUTICS, 2011, 10 (09) : 1698 - 1708